These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1106 related items for PubMed ID: 17339853

  • 1. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH, Munck LK.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [Abstract] [Full Text] [Related]

  • 2. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC, Hanauer SB.
    Rev Gastroenterol Disord; 2004 Mar; 4(3):104-17. PubMed ID: 15359211
    [Abstract] [Full Text] [Related]

  • 3. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H, Munakata A, Yoshida Y.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [Abstract] [Full Text] [Related]

  • 4. Review article: aminosalicylates in inflammatory bowel disease.
    Hanauer SB.
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():60-5. PubMed ID: 15352896
    [Abstract] [Full Text] [Related]

  • 5. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B.
    Tidsskr Nor Laegeforen; 2003 Sep 25; 123(18):2565-7. PubMed ID: 14714043
    [Abstract] [Full Text] [Related]

  • 6. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
    Ryan BM, Russel MG, Langholz E, Stockbrugger RW.
    Am J Gastroenterol; 2003 Aug 25; 98(8):1682-7. PubMed ID: 12907319
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ.
    Rev Gastroenterol Disord; 2006 Aug 25; 6(2):97-105. PubMed ID: 16699478
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN, Nugent Z, Blanchard JF.
    Am J Gastroenterol; 2011 Apr 25; 106(4):731-6. PubMed ID: 21407180
    [Abstract] [Full Text] [Related]

  • 11. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF.
    Aliment Pharmacol Ther; 2006 Oct 25; 24 Suppl 3():64-7. PubMed ID: 16961748
    [Abstract] [Full Text] [Related]

  • 12. Sulfasalazine and 5-ASA compounds.
    Allgayer H.
    Gastroenterol Clin North Am; 1992 Sep 25; 21(3):643-58. PubMed ID: 1355468
    [Abstract] [Full Text] [Related]

  • 13. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
    Kreisel W, Wolf LM, Grotz W, Grieshaber M.
    Eur J Gastroenterol Hepatol; 1996 May 25; 8(5):461-8. PubMed ID: 8804875
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B, Martínez-Cuesta MA, Calatayud S, Hinojosa J, Esplugues JV.
    Gastroenterol Hepatol; 1997 May 25; 20(6):322-34. PubMed ID: 9296850
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
    Munakata A, Yoshida Y, Muto T, Tsuchiya S, Fukushima T, Hiwatashi N, Kobayashi K, Kitano A, Shimoyama T, Inoue M.
    J Gastroenterol; 1995 Nov 25; 30 Suppl 8():108-11. PubMed ID: 8563868
    [Abstract] [Full Text] [Related]

  • 17. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K, Fischer C, Klotz U, Heinkel K.
    Dtsch Med Wochenschr; 1982 Jul 23; 107(29-30):1131-4. PubMed ID: 6123426
    [Abstract] [Full Text] [Related]

  • 18. Pancreatitis in inflammatory bowel diseases.
    Pitchumoni CS, Rubin A, Das K.
    J Clin Gastroenterol; 2010 Apr 23; 44(4):246-53. PubMed ID: 20087199
    [Abstract] [Full Text] [Related]

  • 19. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
    van Staa TP, Card T, Logan RF, Leufkens HG.
    Gut; 2005 Nov 23; 54(11):1573-8. PubMed ID: 15994215
    [Abstract] [Full Text] [Related]

  • 20. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K.
    Dan Med Bull; 1989 Sep 23; 36(4):378-93. PubMed ID: 2572403
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.